Most anti-aging supplements come with big promises and thin evidence. This one comes with a randomized trial, a top-tier journal, and an effect size that is modest but real enough to be worth discussing. In the DO-HEALTH trial, 1 gram a day of omega-3 slowed several epigenetic aging clocks over three years, by roughly 3 months of biological aging. Stacking it with vitamin D and a simple home exercise routine looked even better on one clock.
The effect is small, though, and the analysis was post hoc. Here is what the data show and what they don't.
What the study did
The paper is Bischoff-Ferrari HA, Gängler S, Wieczorek M, Belsky DW, et al., "Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial," Nature Aging, 2025;5(3):376-385 (PubMed, DOI).
It is a post hoc analysis of 777 participants from DO-HEALTH, a randomized trial in adults aged 70 and older from Switzerland, Germany, Austria, France and Portugal. The trial used a 2x2x2 factorial design, so people could receive any combination of three interventions:
- Vitamin D3: 2,000 IU per day
- Omega-3: 1 g per day (EPA+DHA from algae-derived oil)
- Home strength-exercise program: a simple routine done 3 times per week
Researchers measured four next-generation DNA methylation (DNAm) clocks: PhenoAge, GrimAge, GrimAge2 and DunedinPACE. These clocks read chemical marks on DNA to estimate biological age or the pace of aging. The follow-up was 3 years.
The key results, with the numbers
- Omega-3 alone slowed three of the four clocks: PhenoAge, GrimAge2 and DunedinPACE.
- All three treatments combined had additive benefits on PhenoAge. More interventions meant a bigger slowing on that clock.
- Standardized effects ranged from 0.16 to 0.32 units from baseline to year 3. The authors translate this to 2.9-3.8 months of biological aging.
The authors' own summary is measured: the trial shows "a small protective effect of omega-3 treatment on slowing biological aging over 3 years across several clocks," with an additive protective effect of omega-3, vitamin D and exercise based on PhenoAge.
Three months over three years is not a reversal of aging. It is a small but consistent signal across multiple clocks, in a randomized design that is much stronger evidence than the observational data and small pilots that came before.
Why might omega-3 do this?
The abstract reports what happened to the clocks, not why. Any mechanism here is a hypothesis rather than a finding of this paper. Omega-3 fatty acids are widely studied for their effects on inflammation and metabolic health. Both are tied to the kinds of biological processes that DNAm clocks such as GrimAge2 and DunedinPACE are built to capture. Whether those pathways explain the shift in methylation patterns remains to be shown.
The additive effect on PhenoAge is also interesting. Vitamin D and exercise acted through plausibly different routes than omega-3, which would fit with benefits that add up. But the paper reports this additivity only for PhenoAge, so it should not be generalized to every clock.
The honest limitations
This is where hype should stop:
- It was a post hoc analysis. The epigenetic clock question was not the trial's original primary design, so the findings are better treated as hypothesis-strengthening than as definitive.
- The effect is small. Effect sizes of 0.16-0.32 units, or about 3 months over 3 years, are modest.
- The participants were 70 and older and generally healthy. The results may not carry over to younger people, or to people with significant disease.
- Epigenetic clocks are surrogate markers. A slower clock is not the same as a longer life or fewer diseases. No clock has been proven to predict that an intervention extends lifespan.
- Not every clock moved. Omega-3 alone showed effects on three of the four clocks, and the additive effect was seen on PhenoAge only.
- Conflict of interest disclosure. Senior author S. Horvath is a founder of the nonprofit Epigenetic Clock Development Foundation, which has licensed patents for epigenetic clocks (including GrimAge), and works for Altos Labs. The other authors declared no competing interests.
What it means for you: practical takeaways
What the trial used:
- Omega-3: 1 g per day (EPA+DHA, algae-derived oil in the trial)
- Vitamin D3: 2,000 IU per day
- Exercise: a simple home strength routine, 3 times per week
The paper does not specify an optimal time of day, so there is no evidence-backed "timing hack" here. The trial results apply to daily use over 3 years, not short bursts.
Who it may be relevant for: adults around 70 and older who are generally healthy, which is the population actually studied. Younger biohackers can reasonably find the data interesting, but the effect in them is unproven.
Who should skip it or check first:
- Anyone on blood thinners or other anticoagulant or antiplatelet medication should talk to a doctor before adding omega-3.
- Anyone with a medical condition, on multiple medications, or with specific supplement restrictions should get medical advice first. Vitamin D dosing in particular is best set with a clinician if you have conditions affecting calcium.
- If you have a fish or seafood allergy, check the source of any omega-3 product. The trial used algae-derived oil.
Safety: the doses used (1 g omega-3, 2,000 IU vitamin D3) are moderate, but this summary of the abstract does not cover the trial's full safety data, so individual medical advice still applies.
The bottom line
If you want a low-cost, evidence-backed longevity intervention, this trial gives omega-3 a credible, if modest, case. It slowed multiple biological aging clocks in a randomized setting, and combining it with vitamin D and home strength training looked better still on PhenoAge. But the gain was about 3 months over 3 years, the analysis was post hoc, the participants were older and generally healthy, and clocks are not lifespan outcomes. Treat it as a promising small signal, not a fountain of youth, and confirm it fits your health situation with a doctor.
